Leading Research into Head & Neck Cancer

Analysing new treatment options for Adenoid Cystic Carcinoma (ACC)

Full project title: Analysis of new therapeutic options for adenoid cystic carcinoma

Tag: New treatment

<strong>Tag:</strong> New treatment
The problem

New and improved therapies are urgently required for ACC, with the 15 year survival rate as low as 40%. One reason for this low rate is that ACC recurrence is common and often spreads to the lungs and perineural space, where the tumour develops chemotherapy resistance which significantly reduces treatment options.

The research
The future
Dr Amanda Swain
Dr Amanda Swain
Alexandra Rose
Alexandra Rose

Project type:
PhD Research

Project Leader:
Dr Amanda Swain
Professor Kevin Harrington

Researcher:
Alexandra Rose

Commencement date: October 2016

Length of project:
4 years

Funding provided:
£159,722

Funder:
-

Location:
The Institute of Cancer Research

Help fund this project

For more information on funding this project specifically please email us

Donate now and together we can save more lives by beating cancer sooner.

Follow us

Get in touch

Call 020 3875 8991

Email info@oraclecancertrust.org

Registered-logos-grey

Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 10 Parsons Green House, 27 Parsons Green Lane, London SW6 4HH.